10 / 34
Overall Survival: TPS ≥1%
Presented By Gilberto Lopes at 2018 ASCO Annual Meeting
First Line treatment in PD-L1 > 1% NSCLC
|
|
10 / 34
10 / 34
Overall Survival: TPS ≥1%
Presented By Gilberto Lopes at 2018 ASCO Annual Meeting
First Line treatment in PD-L1 > 1% NSCLC